Julia Lainster

Julia Lainster

HealthTech Solutions Expert
Julia Lainster is an expert in Healthtech with a focus on electronic health records, interoperability standards, and cybersecurity. Her content is geared toward industry leaders and organizations seeking to leverage technology to improve efficiency, accuracy, and security in healthcare delivery. Julia aims to drive digital transformation and innovation in Healthtech.
ICR Leads the Genetic Fight to Defeat Cancer
Tech & Innovation ICR Leads the Genetic Fight to Defeat Cancer

Every year on April 25, the global scientific community pauses to recognize DNA Day, a date that marks the monumental publication of the double-helix structure in 1953 and the triumphant completion of the Human Genome Project in 2003. For the researchers at The Institute of Cancer Research (ICR),

High-Dimensional Immune Profiling – Review
Tech & Innovation High-Dimensional Immune Profiling – Review

Missed by the very blood tests meant to reveal them, too many testicular cancers slip through diagnostic nets just when speed matters most for adolescents and young adults facing life-shaping treatment choices. That gap is precisely what a new high-dimensional immune profiling approach set out to

Can a Stem Cell Injection Heal Chronic Achilles Ruptures?
Research & Development Can a Stem Cell Injection Heal Chronic Achilles Ruptures?

For patients living with a chronic Achilles rupture that has resisted months of therapy and bracing, every step can feel like a wager against pain, weakness, instability, and the fear that a compromised tendon will fail again during even the simplest tasks. Traditional reconstruction can fix the

At Home Colorectal Screening – Review
Research & Development At Home Colorectal Screening – Review

Colorectal cancer remains a top killer, yet traditional screening pathways leave many behind. Clinic-based outreach depends on staffed phone banks, open appointment slots, and patients’ ability to take time off, travel, and navigate insurance rules. In safety-net settings, those frictions stack.

MHRA Approves Higher-Dose Spinraza for 5q SMA
Tech & Innovation MHRA Approves Higher-Dose Spinraza for 5q SMA

Ivan Kairatov brings hands‑on R&D experience in neuromuscular drug development and a clear view of how dosing, delivery, and clinic operations intersect in real life. With the MHRA authorizing a higher‑dose nusinersen regimen, he explains how two 50mg loading doses 14 days apart and 28mg

FDA OKs J&J’s Icotyde, First Oral IL-23 Psoriasis Drug
Research & Development FDA OKs J&J’s Icotyde, First Oral IL-23 Psoriasis Drug

Clinic days often hinge on one question patients ask with a mix of hope and hesitation: is there a pill that can match the clearing power of injections without the needles, the storage hassles, or the crowded appointment calendar. That answer just shifted as the FDA cleared Johnson & Johnson’s

Do Ultra-Processed Foods Harm Us—or Their Nutrients?
Research & Development Do Ultra-Processed Foods Harm Us—or Their Nutrients?

The choice happens in a blink—flavored yogurt cup or plain yogurt with a drizzle of maple syrup—yet the metabolic ripples from that small moment could touch cholesterol, blood pressure, and insulin sensitivity before the month is out, and for millions such split-second picks may shape a decade of

Punjabi Sikh mGWAS Uncovers Novel Lipid-Gene Ties to T2D/CVD
Tech & Innovation Punjabi Sikh mGWAS Uncovers Novel Lipid-Gene Ties to T2D/CVD

A surge of cardiometabolic risk among South Asians has demanded answers that Eurocentric datasets could not fully provide, and a new metabolite genome-wide association study in 3,000 Punjabi Sikh adults delivered evidence-rich clues that cut through long-standing gaps. By profiling 516 lipid

Rectal Cancer Deaths Surge Among Older Millennials
Tech & Innovation Rectal Cancer Deaths Surge Among Older Millennials

The long-standing clinical assumption that colorectal cancer primarily strikes the elderly is collapsing as a silent and aggressive crisis sweeps through a generation of adults once deemed essentially invincible. This demographic shift is not merely a statistical anomaly; it represents a

Is an Herbicide Behind the Rise in Young Colorectal Cancer?
Research & Development Is an Herbicide Behind the Rise in Young Colorectal Cancer?

Ivan Kairatov brings a wealth of biopharma expertise to the table, standing at the intersection of molecular research and clinical innovation. His deep understanding of the "exposome"—the cumulative measure of environmental influences and associated biological responses throughout a

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later